Maxim Group & H.C. Wainwright Analysts Confirm Co-Diagnostics (NADSAQ:CODX) Buy Rating with PTs of $20 and $29
24 nov. 2020 08h00 HE
|
BDA International
New York City, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The global upsurge in COVID-19 has kept testing and Co-Diagnostics (NASDAQ: CODX) under the analysts’ microscope. Within its client circular, the...
Saliva-Based Test Powered by Co-Diagnostics (NASDAQ:CODX) a Game Changer
05 août 2020 07h30 HE
|
BDA International
New York City, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Saliva-Based Test Powered by Co-Diagnostics (NASDAQ:CODX) a Game Changer Maxim reiterate Buy with a price target of $30 Earlier this week,...
H.C. Wainwright reiterates ‘Buy’ for Co-Diagnostics (NASDAQ:CODX) with a $35 Price Target as COVID-19 Surge Boosts Testing Demand
14 juil. 2020 07h30 HE
|
BDA International
New York City, July 14, 2020 (GLOBE NEWSWIRE) -- Analyst Yi Chen of H.C. Wainwright & Co. reiterated his ‘buy’ coverage on Co-Diagnostics (NASDAQ:CODX), the Utah-based molecular diagnostics...
BetterLife Pharma (OTCB:BETRD) CEO Discusses Using Interferons to Defeat ‘Truly Evil Virus’
02 juil. 2020 08h00 HE
|
BDA International
New York City, July 02, 2020 (GLOBE NEWSWIRE) -- The CEO of BetterLife Pharma (OTCQB:BETRD) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, recently...
BetterLife Pharma (OTCQB:BETRD) Believe Inhalation Device Containing Proprietary Interferon May Fight Off COVID-19
30 juin 2020 12h55 HE
|
BDA International
New York, June 30, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRD) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, believe that a coronavirus...
BetterLife Pharma (OTCQB:BETRF): How a Simple Inhaler May Fight Off COVID-19
29 juin 2020 08h00 HE
|
BDA International
New York City, June 29, 2020 (GLOBE NEWSWIRE) -- The emerging biotechnology company BetterLife Pharma (OTCQB: BETRF) (CSE: BETR) (FRANKFURT: NPAT) believe that a coronavirus inhaler therapeutic may...
BetterLife Pharma (OTCQB:BETRF) Looks to Immune Response Drug Interferon a2b as Potential Therapeutic for COVID-19
19 juin 2020 07h56 HE
|
BDA International
New York City, June 19, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRF) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, announced recently that...
Co-Diagnostics (NASDAQ:CODX) to join Russell 2000® and 3000® Indexes
11 juin 2020 11h57 HE
|
BDA International
New York City, New York, June 11, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics (NASDAQ:CODX), announced earlier this week that the molecular diagnostics company is set to join the broad-market Russell...
Co-Diagnostics (NASDAQ:CODX) Analysts Set Price Target Between $30 and $36
28 mai 2020 09h00 HE
|
BDA International
New York City, May 28, 2020 (GLOBE NEWSWIRE) -- Analysts from H.C. Wainwright, Maxim Group and Litchfield Hills have all upgraded or reiterated Co-Diagnostics (NASDAQ: CODX) as “Buy” rating in the...
Co-Diagnostics (NASDAQ:CODX) Part of Silicon Slopes Initiative Inking “Big Dollar Contracts” for Coronavirus Testing
28 avr. 2020 12h25 HE
|
BDA International
New York City, April 28, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a Utah biotech with a unique, patented molecular diagnostic testing platform, recently announced...